mesalamine has been researched along with Mitochondrial Diseases in 1 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Mitochondrial Diseases: Diseases caused by abnormal function of the MITOCHONDRIA. They may be caused by mutations, acquired or inherited, in mitochondrial DNA or in nuclear genes that code for mitochondrial components. They may also be the result of acquired mitochondria dysfunction due to adverse effects of drugs, infections, or other environmental causes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haberman, Y | 1 |
| Karns, R | 1 |
| Dexheimer, PJ | 1 |
| Schirmer, M | 1 |
| Somekh, J | 1 |
| Jurickova, I | 1 |
| Braun, T | 1 |
| Novak, E | 1 |
| Bauman, L | 1 |
| Collins, MH | 1 |
| Mo, A | 1 |
| Rosen, MJ | 1 |
| Bonkowski, E | 1 |
| Gotman, N | 1 |
| Marquis, A | 1 |
| Nistel, M | 1 |
| Rufo, PA | 1 |
| Baker, SS | 1 |
| Sauer, CG | 1 |
| Markowitz, J | 1 |
| Pfefferkorn, MD | 1 |
| Rosh, JR | 1 |
| Boyle, BM | 1 |
| Mack, DR | 1 |
| Baldassano, RN | 1 |
| Shah, S | 1 |
| Leleiko, NS | 1 |
| Heyman, MB | 1 |
| Grifiths, AM | 1 |
| Patel, AS | 1 |
| Noe, JD | 1 |
| Aronow, BJ | 1 |
| Kugathasan, S | 1 |
| Walters, TD | 1 |
| Gibson, G | 1 |
| Thomas, SD | 1 |
| Mollen, K | 1 |
| Shen-Orr, S | 1 |
| Huttenhower, C | 1 |
| Xavier, RJ | 1 |
| Hyams, JS | 1 |
| Denson, LA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Nicotinamide Riboside in Ulcerative Colitis[NCT05561738] | 40 participants (Anticipated) | Interventional | 2024-01-01 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for mesalamine and Mitochondrial Diseases
| Article | Year |
|---|---|
Ulcerative colitis mucosal transcriptomes reveal mitochondriopathy and personalized mechanisms underlying disease severity and treatment response.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Child; Colitis, Ulcerative; Feces; Femal | 2019 |